60643-86-9

• 常用中文名：氨己烯酸
• 常用英文名：Vigabatrin
• CAS号：60643-86-9
• 分子式：C₆H₁₁NO₂
• 分子量：129.157
• 相关类别： 原料药 神经系统用药 抗癫痫及抗惊厥药
• 发布时间：2018-09-29 20:44:35
• 更新时间：2026-07-01 18:28:19
• Vigabatrin, also known as gamma-vinyl-GABA, is an antiepileptic drug that inhibits the breakdown of γ-aminobutyric acid (GABA) by acting as a suicide inhibitor of GABA transaminase (GABA-T). It is a structural analog of GABA, but does not bind to GABA receptors. Vigabatrin is an irreversible suicide inhibitor of gamma-aminobutyric acid transaminase (GABA-T), the enzyme responsible for the catabolism of GABA, which increases the level of GABA in the brain. Vigabatrin is a racemic compound, and its [S]-enantiomer is pharmacologically active.

名称

• 中文名: 氨己烯酸
• 英文名: vigabatrin
• 中文别名: 4-氨基-5-己烯酸; 氨己烯酸 标准品; 氨乙烯酸; 维加巴特林; 氨己烯酸相关杂质; 瓜巴特林杂质; 氨已烯酸; 安己烯酸; VIGABATRIN,IRREVERSIBLE GABA TRANSAMINASE抑制剂; 氨己西酸; 维加巴因
• 英文别名: P109, P-109, P 109, RMI 71754, RMI71754, RMI-71754, MDL 71754, MDL-71754, MDL71754, VIGABATRIN, GAMMA-VINYL-GABA, SABRIL, SABRILEX; sabril; vigabatrinum; Aids088550; 4-Aminohex-5-enoic acid; Sabril; GAMMA-VINYL-GABA; Hexenoic acid, 4-amino; VIGABATRIN //BP; UNII:GR120KRT6K; RMI-71754：Sabril; MFCD00274577; VIGABATRIN; mdl71754; gamma.-Vinyl-.gamma.-aminobutyric acid; Aminohexenoic acid; 4-AMINOHEXENOIC ACID; Vigabatrin solution; EINECS 200-659-6; 4-Amino-5-hexenoic acid; 4-Amincr5-hexenoic acid; [R,S]-4-AMINO-5-HEXENOIC ACID; Vigabatrin, Irreversible GABA transaminase inhibitor; (+/-)-GAMMA-VINYL-GABA; γ-Vinyl-GABA, (R,S)-4-Amino-5-hexenoic acid, 4-Aminohexenoic acid; vigabatrinum [INN_la]; vigabatrine; 4-amino-5-hexenoicacid; Aids-088550; rmi71754; Vigabatrin CRS; vigabatrina; 4-amino-5-hexenoicaci; γ-vinyl-gaba; (±)-Vigabatrin

物化性质

• 密度: 1.1±0.1 g/cm3
• 沸点: 277.7±28.0 °C at 760 mmHg
• 分子式: C₆H₁₁NO₂
• 分子量: 129.157
• 闪点: 121.7±24.0 °C
• 精确质量: 129.078979
• PSA: 63.32000
• LogP: -0.10
• 蒸汽压: 0.0±1.2 mmHg at 25°C
• 折射率: 1.483
• 储存条件: Desiccate at +4°C
• 分子结构:

  1、 摩尔折射率：34.62

  2、 摩尔体积（cm³/mol）：121.3

  3、 等张比容（90.2K）：308.0

  4、 表面张力（dyne/cm）：41.5

  5、 极化率（10-24cm3）：13.72

• 计算化学:

  1.疏水参数计算参考值（XlogP）:无

  2.氢键供体数量:2

  3.氢键受体数量:3

  4.可旋转化学键数量:4

  5.互变异构体数量:无

  6.拓扑分子极性表面积63.3

  7.重原子数量:9

  8.表面电荷:0

  9.复杂度:112

  10.同位素原子数量:0

  11.确定原子立构中心数量:0

  12.不确定原子立构中心数量:1

  13.确定化学键立构中心数量:0

  14.不确定化学键立构中心数量:0

  15.共价键单元数量:1

• 更多:

  1.性状：从乙醇-水结晶。

  2.熔点：209℃。

  3.溶解度：易溶于水。

毒性和生态

毒理学数据: 急性毒性LD50。小鼠(mg／kg)：＞2500腹腔注射。 CHEMICAL IDENTIFICATION RTECS NUMBER : MP7745000 CHEMICAL NAME : 5-Hexenoic acid, 4-amino- CAS REGISTRY NUMBER : 60643-86-9 LAST UPDATED : 199801 DATA ITEMS CITED : 11 MOLECULAR FORMULA : C6-H11-N-O2 MOLECULAR WEIGHT : 129.18 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Human - woman DOSE/DURATION : 80 mg/kg/4D-I TOXIC EFFECTS : Brain and Coverings - changes in surface EEG Behavioral - somnolence (general depressed activity) Behavioral - muscle contraction or spasticity REFERENCE : LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 342,185,1993 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Human - man DOSE/DURATION : 57 mg/kg/2D-I TOXIC EFFECTS : Brain and Coverings - changes in surface EEG Behavioral - hallucinations, distorted perceptions Behavioral - toxic psychosis REFERENCE : LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 342,619,1993 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 3 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 18,225,1990 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 3 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 18,225,1990 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >2500 mg/kg TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - ptosis Behavioral - somnolence (general depressed activity) Skin and Appendages - hair REFERENCE : NEPHBW Neuropharmacology. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.9- 1970- Volume(issue)/page/year: 21,803,1982 ** OTHER MULTIPLE DOSE TOXICITY DATA ** TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 109 gm/kg/1Y-C TOXIC EFFECTS : Brain and Coverings - other degenerative changes Behavioral - food intake (animal) Related to Chronic Data - death REFERENCE : TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 18,225,1990 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 9 gm/kg/90D-I TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - retinal changes (pigmentary depositions, retinitis, other) Nutritional and Gross Metabolic - weight loss or decreased weight gain REFERENCE : TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 15,143,1987 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 73 gm/kg/1Y-C TOXIC EFFECTS : Brain and Coverings - other degenerative changes REFERENCE : TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 18,225,1990 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 25200 mg/kg/12W-I TOXIC EFFECTS : Brain and Coverings - other degenerative changes Related to Chronic Data - death REFERENCE : TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 21,480,1993 ** REPRODUCTIVE DATA ** TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 300 mg/kg SEX/DURATION : female 18 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system REFERENCE : TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 53,34A,1996 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 300 mg/kg SEX/DURATION : female 8 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Embryo or Fetus - other effects to embryo Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) REFERENCE : TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 55,165,1997

安全

• 符号: GHS02, GHS06, GHS08
• 信号词: Danger
• 危害声明: H225-H301 + H311 + H331-H370
• 警示性声明: P210-P260-P280-P301 + P310-P311
• 危害码 (欧洲): Xi
• 风险声明 (欧洲): R36/37/38
• 安全声明 (欧洲): S26-S36
• 危险品运输编码: MP7745000
• WGK德国: 2
• RTECS号: MP7745000
• 海关编码: 2922499990

上下游产品

上游产品  9
7529-16-0 144085-15-4 440366-57-4 54653-25-7
31696-00-1 440366-56-3 440366-55-2 66855-20-7
149815-86-1
下游产品  2
105457-53-2 7529-16-0

制备

5-乙烯基-2-吡咯烷酮(I)和氢氧化钾，在含水异丙醇中进行水解反应，得到氨己烯酸，收率87%。

海关

海关编码	2922499990
中文概述	2922499990 其他氨基酸及其酯及它们的盐（含有一种以上含氧基的除外）. 增值税率:17.0% 退税率:9.0% 监管条件:AB(入境货物通关单,出境货物通关单) 最惠国关税:6.5% 普通关税:30.0%
申报要素	品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装
监管条件	A.入境货物通关单 B.出境货物通关单
检验检疫	P.进境动植物、动植物产品检疫 Q.出境动植物、动植物产品检疫 R.进口食品卫生监督检验 S.出口食品卫生监督检验 M.进口商品检验 N.出口商品检验
Summary	HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%